What is the main business of Science For Health Team?

The main business activity of Science For Health Team focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 9, 2021.

Where is the headquarters located?

The headquarters is located at: ul. Św. Michała 43, 61-119 Poznań.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

What was the revenue?

The company reported a revenue of $36,483 in 2023.

Yes, the company recorded a net profit of $5,388 in 2023.

What is the largest operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $20,987 in 2023, representing 69% of all operating expenses.

Science for Health Teamsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2021-11-09

Share capital

5,000.00 PLN

Registered address

ul. św. Michała 43, 61-119 Poznań, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 1 of 2 financial statements was filed late (for 2022, 254 days late).

2024not filed
202325/03/2024
202225/03/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue

This companyUSD 36.48kMedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD 5.39kMedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 30.51kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 11.50kMedianUSD 133.19kAverageUSD 3.03m

Industry

Research and experimental development on biotechnology (72.11.Z)Primary

Authorized Representatives

Paweł Bąkowski – Management Board Member

Kamilla Grzywacz – President of the Management Board

Joanna Katarzyna Wałecka – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Paweł Bąkowskiage 43	16	$432.20	32%
Kamilla Grzywaczage 48	17	$459.21	34%
Joanna Katarzyna Wałeckaage 40	17	$459.21	34%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2022-03-01 to 2026-08-07.

Reason for removal: Art. 96 ust. 9a pkt 1 (business activity suspended for at least 6 consecutive months)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
GenxoneS.A.	$665,361.35	genxone.eu
Polbiotech Laboratoriumsp. z o.o.	$645,943.81	polbiotech.pl
Relvosp. z o.o.	$120,693.26	relvo.pl
Microblicsp. z o.o.	$122,383.50	microblic.pl
Xenstatssp. z o.o.	$66,774.27	xenstats.com
Zawamedsp. z o.o.	$43,909.06	zawamed.pl
Stenocoatsp. z o.o.	$36,665.21	stenocoat.com
Fungotechsp. z o.o.	$187.68	fungo.tech
Dystrogen TherapeuticsS.A.	–	dystrogen.com
MIMO BiotechP.S.A.	–	mimobiotech.com

Change history

Date	Event
2026-02-01	Business suspended
2021-12-21	Address change (Ul. Św. Michała 43, 60-201, Poznań → Ul. Św. Michała 43, 61-119, Poznań)
2021-11-09	Entered in the register

FAQ

Last updated: 2026-04-08